The authors suggested that compounds 86, apart from arresting the growth of hepatoma cells in the S phase, induce apoptosis in hepatoma cells, down-regulate the expression of C-myc, CDK2 and CyclinE, and up-regulate the level of p53. The gene discussed is TP53; the disease is hepatocellular carcinoma.